Common Contracts

6 similar Registration Rights Agreement contracts by Alzamend Neuro, Inc., Borqs Technologies, Inc., Guerrilla RF, Inc., others

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • May 9th, 2024 • Alzamend Neuro, Inc. • Pharmaceutical preparations

This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and the Purchaser (the “Purchase Agreement”).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • April 1st, 2024 • Guerrilla RF, Inc. • Semiconductors & related devices

This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 28, 2024, by and between Guerrilla RF, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • November 18th, 2022 • Ideanomics, Inc. • Motor vehicles & passenger car bodies

This Registration Rights Agreement (this “Agreement”) is made and entered into as of November 14, 2022, between Ideanomics, Inc., a company incorporated in Nevada (the “Company”) and the investors signatory hereto (collectively, the “Buyer”).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • April 26th, 2021 • Borqs Technologies, Inc. • Services-computer integrated systems design

This Registration Rights Agreement (this “Agreement”) is made and entered into as of February __, 2021, between Borqs Technologies, Inc., a company incorporated in the British Virgin Islands (the “Company”) and the investors signatory hereto (collectively, the “Buyer”).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • June 19th, 2019 • ReShape Lifesciences Inc. • Electromedical & electrotherapeutic apparatus
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • December 31st, 2018 • Innovus Pharmaceuticals, Inc. • Pharmaceutical preparations

This Registration Rights Agreement (this “Agreement”) is made and entered into as of December 30, 2018, between Innovus Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).